Ascendis Pharma

Contributing Author

Recent Articles by Ascendis Pharma

May-13	New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon CNP (Navepegritide) ASND GlobeNewswire
May-12	New 4-Year Data Shows Sustained Response to TransCon PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism ASND GlobeNewswire
May-05	Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025 ASND GlobeNewswire
May-01	Ascendis Pharma Reports First Quarter 2025 Financial Results ASND GlobeNewswire